Group 1 - The core viewpoint of the news is that 技源集团 (Jiyuan Group) has shown fluctuations in its stock performance and financing activities, with a slight decline in stock price and specific data on financing and margin trading [1] - On August 22, 2023, Jiyuan Group's stock price decreased by 0.32%, with a trading volume of 1.11 billion yuan. The financing buy-in amount was 13.45 million yuan, while the financing repayment was 13.49 million yuan, resulting in a net financing buy of -46,700 yuan [1] - As of August 22, 2023, the total balance of margin trading for Jiyuan Group was 59.59 million yuan, which accounted for 4.99% of its circulating market value [1] Group 2 - As of July 23, 2023, the number of shareholders for Jiyuan Group reached 62,200, representing an increase of 478,138.46% compared to the previous period [2] - For the first quarter of 2025, Jiyuan Group reported a revenue of 265 million yuan, reflecting a year-on-year growth of 16.59%. The net profit attributable to the parent company was 42.60 million yuan, with a year-on-year increase of 9.25% [2] - The company's main business involves the research, innovation, and industrialization of dietary nutritional supplements, with revenue contributions from various products including HMB (29.29%), tablets (22.53%), glucosamine (17.66%), and others [1]
技源集团8月22日获融资买入1344.75万元，融资余额5959.93万元